Form 4: Paychex Director Joseph Doody Receives Equity Awards
Insider Transaction Report
Paychex Director Joseph Doody reported the acquisition of restricted stock units and stock options as part of compensation.
Summary
- Joseph Doody, a Director of Paychex Inc. (PAYX), reported the acquisition of 725 shares of common stock in the form of restricted stock units (RSUs) on October 15, 2025. These RSUs were awarded at a price of $0 and are subject to vesting under the Amended and Restated 2002 Stock Incentive Plan.
- Doody also acquired 3,061 stock options on October 15, 2025, with an exercise price of $127.52. These options become exercisable on October 15, 2026, and expire on October 14, 2035.
- Following these transactions, Doody directly beneficially owns 889 shares of common stock and indirectly owns 23,758 shares through the Joseph G. Doody Revocable Living Trust.
- His direct beneficial ownership of derivative securities (stock options) now totals 32,288 options, including the newly acquired 3,061 options and previously held options with various exercise prices and expiration dates.
Sentiment
Score: 6
Explanation: The filing reports the acquisition of equity awards by a director, which aligns management interests with shareholders, though it represents compensation rather than an open market purchase.
Positives
- Director Joseph Doody acquired 725 restricted stock units and 3,061 stock options, which aligns his interests with long-term shareholder value.
- The equity awards are part of a compensation plan, indicating ongoing commitment and incentivization for the director.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Equity Incentive Plan | Awards made pursuant to the Amended and Restated 2002 Stock Incentive Plan. | 10/15/2025 | Aligns director's interests with long-term shareholder value through equity-based compensation. |
Stakeholder Impact
- Shareholders: Increased alignment of director's interests with shareholder value through equity compensation.
Key Dates
| Date | Description |
|---|---|
| 07/11/2020 | Date exercisable for 7,929 stock options |
| 07/15/2021 | Date exercisable for 5,793 stock options |
| 07/15/2022 | Date exercisable for 5,075 stock options |
| 07/15/2023 | Date exercisable for 3,027 stock options |
| 07/15/2024 | Date exercisable for 3,382 stock options |
| 07/14/2025 | Date exercisable for 3,351 stock options |
| 10/15/2025 | Date of earliest transaction, including acquisition of 725 restricted stock units and 3,061 stock options |
| 10/17/2025 | Date the Form 4 was signed and filed |
| 10/15/2026 | Date exercisable for the newly acquired 3,061 stock options |
| 07/15/2026 | Date exercisable for 670 stock options |
| 07/10/2029 | Expiration date for 7,929 stock options |
| 07/14/2030 | Expiration date for 5,793 stock options |
| 07/14/2031 | Expiration date for 5,075 stock options |
| 07/14/2032 | Expiration date for 3,027 stock options |
| 07/14/2033 | Expiration date for 3,382 stock options |
| 07/14/2034 | Expiration date for 3,351 stock options |
| 07/14/2035 | Expiration date for 670 stock options |
| 10/14/2035 | Expiration date for the newly acquired 3,061 stock options |
Recommendation
holdThe Form 4 filing details routine equity compensation awards to a director, which is a standard practice for aligning management incentives with shareholder interests. While the acquisition of shares and options by an insider can be seen as a positive signal, these are compensation awards rather than open market purchases, thus not indicating a strong conviction buy. The filing does not provide sufficient information to alter a fundamental investment thesis, hence a 'hold' recommendation is appropriate based solely on this disclosure.
Keywords
Paychex, PAYX, Joseph Doody, Form 4, Insider Transaction, Restricted Stock Units, Stock Options, Director Compensation, Equity Awards
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.